PLASMA CONCENTRATION OF ENDOTHELIN-1 IN PATIENTS WITH HYPERTENSION ASSOCIATED WITH OBESITY, DEPENDING ON THE LYS198ASN POLYMORPHISM OF THE ENDOTHELIN-1 GENE
Article PDF (Українська)

Keywords

Lys198Asn polymorphism, genotype, endothelin-1, gene of endothelin-1

How to Cite

Yu. O. Smiianova. (2021). PLASMA CONCENTRATION OF ENDOTHELIN-1 IN PATIENTS WITH HYPERTENSION ASSOCIATED WITH OBESITY, DEPENDING ON THE LYS198ASN POLYMORPHISM OF THE ENDOTHELIN-1 GENE. Eastern Ukrainian Medical Journal, 9(1), 87-94. https://doi.org/10.21272/eumj.2021;9(1):87-94

Abstract

Endothelial dysfunction is considered one of the main mechanisms for the further development of arterial hypertension (AH) and its complications, and endothelin-1 (ЕТ-1) plays one of the key roles in this process. Endothelium is drawn into the pathological process at the earliest stages of AH development. ЕТ-1 is currently considered as a marker and predictor of the stage and consequences of AH, chronic heart failure (CHF), coronary heart disease (CHD), in particularly, acute myocardial infarction (MI), heart rhythm disorders, pulmonary hypertension, atherosclerotic vascular injury, target vascular disorders.

One factor that may influence the level of ЕТ-1 is the endothelin-1 gene Lys198Asn polymorphism, which is considered by many researchers as a possible genetic marker of AH. However, the effect of this polymorphism on the level of plasma ЕТ-1 level in patients with AH of varying severity in Ukraine is understudied.

The basis of this work were the materials of a complete examination of 160 patients with a verified diagnosis of AH I, stage II of 1, 2, 3 degrees (main group) and 110 apparently healthy persons (control group). Patients of the main group were divided into three subgroups: 1st group ­– 75 patients with normal body weight; 2nd group – 48 overweight patients; 3rd group – 37 patients with alimentary obesity. In obese patients, the waist circumference in women was around 103 (96–115) cm, and in men – 108 (105–116) cm, which indicates an abdominal type of obesity in these patients.

As a result of the study, it was found that the level of ЕТ-1 is higher in patients with AH who suffer with overweight and obesity as compared with patients with AH and normal body weight. Also, the peptide level depends on the genotype of patients and is higher in AH patients with the genotype Asn198Asn and Lys198Asn as compared to carriers of the genotype Lys198Lys.

https://doi.org/10.21272/eumj.2021;9(1):87-94
Article PDF (Українська)

References

1. Krüger-Genge A, Blocki A, Franke R, Jung F. Vascular endothelial cell biology: an update. International Journal of Molecular Sciences. 7. 09. 2019; 20 (18): 4411. DOI: 10.3390 / ijms20184411.
2. Mordi I, Mordi N, Delles C, Tzemos N. Endothelial dysfunction in human essential hypertension. Hypertens, 2016; Aug; 34(8):1464-72. doi: 10.1097/HJH.0000000000000965.
3. Aflyatumova GN, Nigmatullina RR, Sadykova DI, Chibireva MD, Fugetto F, Serra R. Endothelin-1, nitric oxide, serotonin and high blood pressure in male adolescents. Vasc Health Risk Manag. 2018 Sep 18;14:213-223. doi: 10.2147/VHRM.S170317.
4. Manini AF, Gibson CL, Miller ML, Richardson LD, Vargas-Torres CC, Vedanthan R, Hurd YL. Biomarkers of endothelial dysfunction in cocaine overdose and overdose-related cardiovascular events Addict Biol. 2021 Mar; 26 (2): e12901. doi: 10.1111/adb.12901.
5. Berezikova EN. [Kliniko–geneticheskie i nejrogormonal'nye mekhanizmy razvitiya ishemicheskogo remodelirovaniya, apoptoza miokarda i serdechnoj nedostatochnosti: innovacionnaya strategiya personalizirovannoj diagnostiki, profilaktiki i lecheniya]: Avtoref. dis. .... dokt. med. nauk: 14.01.05. Tomsk, 2014. 49 s.
6. Barаth А, Endreffy, Bereczkin Cs. et al. Endothelin–1 gene and endothelial nitric oxidesynthase gene polymorphisms in adolescentswith juvenile and obesity–associatedhypertension. Acta Physiologica Hungarica. 2007; 94(1–2):49–66. DOI: 10.1556/APhysiol.94.2007.1-2.6.
7. Dzholdasbekova AU. Gaipov AE. The Association Between Polymorphism of Lys198Asn of Endothelin–1 Gene and Arterial Hypertension Risk in Kazakh People. Eur J Gen Med. 2010; 7(2):187–191. https://doi.org/10.29333/ejgm/82848
8. Palagnyuk GO, Pashkova YuP, Ruzhanska VO, Zhebel VM. [Sposib prohnozuvannia ryzyku rozvytku neuskladnenoi hipertonichnoi khvoroby u cholovikiv vikom 40-60 rokiv]. Materialy naukovo-praktychnoi konferentsii «Standarty diahnostyky ta likuvannia v klinitsi vnutrishnikh khvorob». [Materialy naukovo-praktychnoi konferentsii «Standarty diahnostyky ta likuvannia v klinitsi vnutrishnikh khvorob»]. – Vinnytsia, 15-16 kvitnia 2015. – S. 56-57.
9. Minushkina LO. Geneticheskie faktory pri gipertonicheskoj bolezni: svyaz' s osobennostyami techeniya, razvitiem oslozhnenij, effektivnost'yu terapii: dissertacziya doktora mediczinskikh nauk: 14.00.06. Moskva, 2008. - 288 s.
10. Palahniuk H. The relationship between plasma endothelin-1 concentrations and ET-1 gene polymorphism in men with essential hypertension. Journal of Hypertension: the 26th Scientific Meeting of the International Society of Hypertension. Seul, September 24-29.2016;34:97. DOI: 10.1097/01.hjh.0000500104.25775.91
11. Shcheglova EV. [Klinicheskoe i prognosticheskoe znachenie polimorfizma nekotoryh genov–kandidatov i markyorov endotelial'noj disfunkcii u bol'nyh, perenyosshih ostryj koronarnyj sindrom]. Avtoref. dis. .... kand. med. nauk: 14.00.05. Vladikavkaz, 2008. 23 s.
12. Vadapalli S, Rani HS, Sastry B. Endothelin-1 and endothelial nitric oxide polymorphisms in idiopathic pulmonary arterial hypertension. International Journal of Molecular Epidemiology and Genetics, 15 Jun 2010, 1(3):208-213 PMID: 21537392
13. Diamanti–Kandarakis E. Spina G, Kouli C, et al. Increased Endothelin–1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy. The Journal of Clinical Endocrinology & Metabolism. 2001; 86(10):4666–4673. DOI: 10.1210/jcem.86.10.7904.
14. Głowińska B, Urban M, Hryniewicz A et al. Endothelin–1 plasma concentration in children and adolescents with atherogenic risk factors. Kardiol Pol. 2004; 61(10):329–38 PMID: 15841114
15. Poole-Wilson PA, Swedberg K, Cleland JG et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2008; 362:7–13. DOI: 10.1016 / S0140-6736 (03) 13800-7.
16. Ferri C, Bellini C, Desideri G et al. Plasma Endothelin-1 Levels in Obese Hypertensive and Normotensive. Men. Diabetes. 1995; 44(4):431–436. DOI: 10.2337/diab.44.4.431.
17. Aziza L, Sja’bani M, Mubarika Haryana S et al. The Relationship Between Endothelin-1 and Hypertension on Mlati Population, Sleman, Yogyakarta, Indonesia. J Indon Med Assoc. 2011; 61(6):237–242.
18. Hoffman A, Grossman E, Goldstein DS, et al. Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int. 1994; 45(2):556–560. https://doi.org/10.1038/ki.1994.72
19. Letizia C, Subioli S, Cerci S, et al. Effects of captopril on plasma endothelin-1 in patients with essential hypertension. J Clin Basic Cardiol. 1999; 2:75–77.
20. Petrovska VV, Zhebel VM. [Paraleli strukturno–funktsionalnykh pokaznykiv miokarda ta kontsentratsii u plazmi S–natriiuretychnoho peptydu y endotelinu-1 u zhinok iz neuskladnenoiu hipertonichnoiu khvoroboiu]. Aktualni pytannia farmacevtychnoyi i medychnoyi nauky ta praktyky. 2014; 3(16):84–87. DOI: 10.13140/RG.2.1.4823.9768
21. Vilchynskyi HV, Franchuk SV, Zhebel VM. [Plazmovi kontsentratsii S-natriiuretychnoho peptydu ta endotelinu-1 u zhinok pisliamenopauzalnoho viku, khvorykh na hipertonichnu khvorobu riznoi stadii]. Visnyk problem biologiyi ta medytsyny. 2012; 1(91):100–103.
22. Stepanets SO. [Plazmovi kontsentratsii S-natriiuretychnoho peptydu ta endotelinu-1 u cholovikiv khvorykh na hipertonichnu khvorobu z riznymy henotypamy pyroksysom proliferator–aktyvuiuchykh retseptoriv hamma]. Viomedical and biosocial anthropology. 2013; 21:180–184
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.